Japanese Pharmaceutical Company Touts Ivermectin’s ‘Antiviral Effect’ Against COVID-19

  • by:
  • 09/21/2022

Japanese trading and pharmaceutical company Kowa Co. Ltd. said Monday that ivermectin shows an “antiviral effect” against the omicron variant and others. 

The statement was based on joint, non-clinical trials the company has been running with Tokyo’s Kitasato University, Just the News reports

It is no secret that the drug is extremely controversial. It is not approved for use in treating the virus in Japan, and in the U.S., the FDA continues to caution against its use. 

While the FDA argues there have been a number of cases in which people were hospitalized after self-medicating with the drug, there have also been several cases of it being used to successfully treat COVID-19 in unvaccinated and vaccinated patients. 

Ivermectin is currently being studied in the United Kingdom in a trial through Oxford University. 

N/A by N/A is licensed under N/A

Opinion

View All

Pop Culture Warriors: Michael Malice

'I learned English by watching Three's Company.'...

MARSCHALL: Bye Ilhan! – House Finally Purges Foreign Affairs Committee of Dangerous Antisemite

'I wasn’t aware of the fact that there are tropes about Jews and money.'...

Virginia Gov. Glenn Youngkin Enjoying 56 Percent Approval Ratings, Strong Support For Agenda

"Virginia is showing strong support for his agenda," a Richmond official told the Examiner....

Greta Thunberg is Fair Game for Mockery

Thunberg is no longer a 14-year-old child, but a 20-year-old woman....

© 2023 Human Events, Privacy Policy